Interferon alfa in the treatment paradigm for non–muscle-invasive bladder cancer

In this article, we review the various options for and the potential role of interferon alfa (IFN-α) in the treatment of non–muscle-invasive bladder cancer (NMIBC). PubMed was searched for journal articles on IFN-α use in treating bladder cancer. The references listed in the National Comprehensive Cancer Network guidelines were used as a guide to identify relevant publications on treatments for NMIBC. Transurethral resection with adjuvant...